Clinuvel (UK) Ltd.
🇬🇧United Kingdom
Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers
Phase 1
Completed
- Conditions
- Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
- Interventions
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Clinuvel (UK) Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT05368857
- Locations
- 🇬🇧
CLINUVEL Investigational Site, Clinuvel Investigational Site, United Kingdom
News
No news found